Big Pharma Boosts Drug Prices As Supplies Run Low, Study Reveals

Drug companies display “opportunistic behavior” while pricing products that are in short supply, the authors of a new study allege.

Read the full post on Forbes - Healthcare

Arlene Weintraub, Contributor